Graves Kurt

EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA · on record since Oct 21, 2009
Director at MPM ACQUISITION CORP · on record since May 19, 2011
Director at ACHILLION PHARMACEUTICALS INC · on record since Jun 13, 2012
Director at Ruthigen, Inc. · on record since Jun 17, 2015
Director at Seres Therapeutics, Inc. · on record since Nov 10, 2015

Insider trading activity of Graves Kurt

Transactions on record: 104; since Jul 18, 2007

Open-market buys: 7; $100.3K

Open-market sells: 33; $5.6M

Companies traded: 5; last filing Apr 11, 2025

Figures computed from official regulatory filings — methodology.

Companies where Graves Kurt has traded

Seres Therapeutics, Inc.13 tx · Apr 11, 2025
MPM ACQUISITION CORP28 tx · $6.3M · Feb 24, 2020
ACHILLION PHARMACEUTICALS INC15 tx · $143.1K · Jan 29, 2020
Ruthigen, Inc.4 tx · Feb 25, 2016
VERTEX PHARMACEUTICALS INC / MA44 tx · $697.8K · Oct 21, 2009

Track record of Graves Kurt

Statistical track record

Free

Open-market buys: 7

Last buy: Nov 6, 2007

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Graves Kurt

Co-insiders of Graves Kurt

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Seres Therapeutics, Inc.	Apr 11, 2025	AwardD	100,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jul 3, 2024	AwardD	64,564	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Apr 8, 2024	AwardD	60,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 23, 2023	AwardD	35,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 24, 2022	AwardD	35,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 24, 2022	AwardD	35,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 21, 2021	AwardD	23,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 22, 2020	AwardD	30,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 24, 2020	AwardD	10,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 24, 2020	Award	5,500	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-135,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-42,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	Other	-22,709	6.30 USD	$143.1K	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-25,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-30,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-30,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-30,000	—	—	SEC
Seres Therapeutics, Inc.	Jun 14, 2019	AwardD	15,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Apr 18, 2019	Sell	-4,800	22.32 USD	$107.1K	SEC
MPM ACQUISITION CORP	Feb 26, 2019	Award	5,500	—	—	SEC
MPM ACQUISITION CORP	Feb 26, 2019	AwardD	10,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 13, 2019	ExerciseD	-4,800	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 13, 2019	Exercise	4,800	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 25, 2019	AwardD	42,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 27, 2018	AwardD	15,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Seres Therapeutics, Inc.	Apr 11, 2025	AwardD	100,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jul 3, 2024	AwardD	64,564	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Apr 8, 2024	AwardD	60,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 23, 2023	AwardD	35,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 24, 2022	AwardD	35,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 24, 2022	AwardD	35,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 21, 2021	AwardD	23,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 22, 2020	AwardD	30,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 24, 2020	AwardD	10,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 24, 2020	Award	5,500	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-135,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-42,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	Other	-22,709	6.30 USD	$143.1K	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-25,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-30,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-30,000	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 29, 2020	OtherD	-30,000	—	—	SEC
Seres Therapeutics, Inc.	Jun 14, 2019	AwardD	15,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Apr 18, 2019	Sell	-4,800	22.32 USD	$107.1K	SEC
MPM ACQUISITION CORP	Feb 26, 2019	Award	5,500	—	—	SEC
MPM ACQUISITION CORP	Feb 26, 2019	AwardD	10,000	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 13, 2019	ExerciseD	-4,800	0.00 USD	$0	SEC
MPM ACQUISITION CORP	Feb 13, 2019	Exercise	4,800	—	—	SEC
ACHILLION PHARMACEUTICALS INC	Jan 25, 2019	AwardD	42,000	0.00 USD	$0	SEC
Seres Therapeutics, Inc.	Jun 27, 2018	AwardD	15,000	0.00 USD	$0	SEC